A Pilot Study of OncoSil™ Given to Patients With Pancreatic Cancer Treated With FOLFIRINOX or Gemcitabine+Abraxane

Name: A Pilot Study of OncoSil™ Given to Patients With Pancreatic Cancer Treated With FOLFIRINOX or Gemcitabine+Abraxane
Published: 2017
License: Public Domain

OncoSil Medical Limited · 2017

ClinicalTrials.gov · Datasets · License: Public Domain · 2017

Open Source ↗

device pancreatic-cancer

unresectable locally advanced pancreatic carcinoma, pancreatic cancer, pancreas, metastases, pancreatic tumour, unresectable, locally advanced, implantable, radiographic, device, phosphorous-32, oncosil™

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 885659
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.